Alexion Global Site | Website analytics by TrustRadar
Blurry colored background
alexion.com Biopharmaceuticals Rare Diseases Healthcare Research and Development

Alexion Global Site

As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.

Alexion.com is the official website of Alexion Pharmaceuticals, Inc., a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development, and commercialization of life-changing therapies. The site provides comprehensive information about the company's mission, research, products, and how they are making a difference in the lives of those with rare diseases.

Unique Visits

240K

8000 / day

Total Views

360K

12000 / day

Visit Duration, avg.

3.8 min

3.2 pages per visit

Bounce Rate

45%

  • Domain Rating

  • Domain Authority

  • Citation Level

Founded in

1992

Supported Languages

English, etc

Website Key Features

Patient Support

Information and resources for patients and families, including access to therapy, financial assistance, and educational materials.

Research and Development

Details on Alexion's innovative research and development efforts aimed at addressing unmet medical needs in rare diseases.

Product Information

Comprehensive information on Alexion's approved therapies, including indications, safety information, and prescribing details.

Careers

Explore career opportunities at Alexion, including job openings, company culture, and employee benefits.

Investor Relations

Financial information, news, and events for investors and stakeholders interested in Alexion's business and financial performance.

News and Media

Latest news, press releases, and media resources from Alexion Pharmaceuticals.

Global Presence

Information on Alexion's operations and offices around the world, highlighting its global commitment to serving patients with rare diseases.

Additional information

Headquarters

Boston, Massachusetts, United States

Number of Employees

Over 3,000 globally

Key People

Ludwig Hantson, CEO; John Orloff, Head of Research and Development

Revenue

Reported revenue of over $5 billion in recent years

Stock Ticker

ALXN (NASDAQ)

Awards and Recognition

Recipient of numerous awards for innovation, workplace environment, and commitment to rare disease communities

Community Engagement

Active participation in and support for rare disease communities through partnerships, sponsorships, and patient advocacy

HTTP headers

Security headers report is a very important part of user data protection. Learn more about http headers for alexion.com